CRMP1 and Behcet disease: In contrast to BD cases, comparisons of baseline and 6th-week mRNA levels of GSK3β and CRMP1 among six control subjects, who repeated biopsy, did not reveal this pattern of reduction of the second (i.e., 6th week) mRNA levels from their baseline levels (Supplementary Figure 6).